Evidence map›Paper›PMID 39538968›Full record

ReviewGut microbes

Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health.

Mohan Li, Bingyong Mao, Xin Tang, Qiuxiang Zhang, Jianxin Zhao, Wei Chen, Shumao Cui

Abstract readReview
In one paragraph

Review in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Membrane Vesicles fromInternational journal of molecular sciences · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohan LiState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Bingyong MaoState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Xin TangState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Qiuxiang ZhangState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Jianxin ZhaoState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.
Wei ChenState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.ORCID 0000-0003-3348-4710
Shumao CuiState Key Laboratory of Food Science and Resources, Jiangnan University, Wuxi, Jiangsu, China.ORCID 0000-0002-7055-0484

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactic acid bacteria derived extracellular vesicles (LAB-EVs) are nano-sized and carry a variety of biological cargoes. LAB-EVs have proven to be potential mediators of intercellular communication, serving not only the parental bacteria but also the host cell in both physiology and pathology. LAB-EVs are therapeutically beneficial in various diseases through a cell-free strategy. Particularly, EVs secreted from probiotics can exert health-promoting effects on humans. Additionally, the excitement around LAB-EVs has extended to their use as nano-sized drug carriers, since they can traverse biological barriers. Nevertheless, significant challenges in terms of isolation, characterization, and safety must be addressed to ensure the clinical application of LAB-EVs. Therefore, this review emphasizes the isolation and purification methods of LAB-EVs. We also introduce the biogenesis, cargo sorting, and functions of LAB-EVs. The biological regulatory factors of LAB-EVs are summarized and discussed. Special attention is given to the interaction between LAB-EVs and the host, their ability to maintain intestinal homeostasis, and the immunity and inflammation they induce in diverse diseases. Furthermore, we summarize the characterization of LAB-EV cargoes by advanced analytical methods such as proteomics. Finally, we discuss the challenges and opportunities of LAB-EVs as a means of diagnosis and treatment in clinical translation. In conclusion, this review scrutinizes current knowledge and provides guidelines for proposing new perspectives for future research in the field of LAB-EVs.

Indexed as

Extracellular VesiclesLactobacillalesNanoparticlesProbioticsAnimalsGastrointestinal MicrobiomeHumansbiogenesisdiseasesfFunctionisolation and purification methodsLactic acid bacteria derived EV (LAB-EVs)

Identifiers

PMID39538968
PMCPMC11572086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.